Skip to main content
PMC home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1980 Nov;101(2):425–484.

Viral myocarditis. A review.

J F Woodruff
PMCID: PMC1903609  PMID: 6254364

Full text

PDF
425

Images in this article

481Figure 1
on p.481
481Figure 2
on p.481
483Figure 3
on p.483
483Figure 4
on p.483

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ABELMANN W. H., KOWALSKI H. J., McNEELY W. F. Cardiovascular studies during acute infectious hepatitis. Gastroenterology. 1954 Jul;27(1):61–66. [PubMed] [Google Scholar]
  2. ADAMS C. W. Postviral myopericarditis associated with the influenza virus; report of eight cases. Am J Cardiol. 1959 Jul;4(1):56–67. doi: 10.1016/0002-9149(59)90193-6. [DOI] [PubMed] [Google Scholar]
  3. AGRANAT A. L. A near-fatal case of Coxsackie B1 myocarditis (with pericarditis) in an adult. S Afr Med J. 1961 Oct 7;35:831–833. [PubMed] [Google Scholar]
  4. AHVENAINEN E. K. Inclusion disease or generalized salivary gland virus infection; report of five cases. Acta Pathol Microbiol Scand Suppl. 1952 Jun;93:159–167. [PubMed] [Google Scholar]
  5. ANDERSON T., FOULIS M. A., GRIST N. R., LANDSMAN J. B. Clinical and laboratory observations in a small pox outbreak. Lancet. 1951 Jun 9;1(6667):1248–1252. doi: 10.1016/s0140-6736(51)92754-7. [DOI] [PubMed] [Google Scholar]
  6. ARONSON S. M., SHWARTZMAN G. Histopathogenesis of cortisone-altered experimental poliomyelitis; observations on the Syrian hamster inoculated intracerebrally with strain MEF1. Am J Pathol. 1953 May-Jun;29(3):381–399. [PMC free article] [PubMed] [Google Scholar]
  7. Abelmann W. H. Viral myocarditis and its sequelae. Annu Rev Med. 1973;24:145–152. doi: 10.1146/annurev.me.24.020173.001045. [DOI] [PubMed] [Google Scholar]
  8. Adesanya C. O., Goldberg A. H., Phear W. P., Thorp K. A., Young N. A., Abelmann W. H. Heart muscle performance after experimental viral myocarditis. J Clin Invest. 1976 Mar;57(3):569–575. doi: 10.1172/JCI108312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ainger L. E., Lawyer N. G., Fitch C. W. Neonatal rubella myocarditis. Br Heart J. 1966 Sep;28(5):691–697. doi: 10.1136/hrt.28.5.691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Almeida J. D., Waterson A. P. The morphology of virus-antibody interaction. Adv Virus Res. 1969;15:307–338. doi: 10.1016/S0065-3527(08)60878-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Atkinson J. P., Schreiber A. D., Frank M. M. Effects of corticosteroids and splenectomy on the immune clearance and destruction of erythrocytes. J Clin Invest. 1973 Jun;52(6):1509–1517. doi: 10.1172/JCI107325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. BAIN H. W., McLEAN D. M., WALKER S. J. Epidemic pleurodynia (Bornholm disease) due to Coxsackie B-5 virus. The inter-relationship of pleurodynia, benign pericarditis and aseptic meningitis. Pediatrics. 1961 Jun;27:889–903. [PubMed] [Google Scholar]
  13. BENGTSSON E., ORNDAHL G. Complications of mumps with special reference to the incidence of myocarditis. Acta Med Scand. 1954;149(5):381–388. doi: 10.1111/j.0954-6820.1954.tb11449.x. [DOI] [PubMed] [Google Scholar]
  14. BENIRSCHKE K., KIBRICK S. Acute aseptic myocarditis and meningoencephalitis in the newborn child infected with coxsackle virus group B, type 3. N Engl J Med. 1956 Nov 8;255(19):883–889. doi: 10.1056/NEJM195611082551902. [DOI] [PubMed] [Google Scholar]
  15. BODEY G. P., WERTLAKE P. T., DOUGLAS G., LEVIN R. H. CYTOMEGALIC INCLUSION DISEASE IN PATIENTS WITH ACUTE LEUKEMIA. Ann Intern Med. 1965 May;62:899–906. doi: 10.7326/0003-4819-62-5-899. [DOI] [PubMed] [Google Scholar]
  16. BORING W. D., WALKER D. L., ZU RHEIN G. M. Factors influencing host-virus interactions. II. Alteration of Coxsackie virus infection in adult mice by cold. Proc Soc Exp Biol Med. 1956 Nov;93(2):273–277. doi: 10.3181/00379727-93-22730. [DOI] [PubMed] [Google Scholar]
  17. BRADFORD H. A., ANDERSON L. L. Electrocardiographic observations during a poliomyelitis epidemic. Ann Intern Med. 1950 Feb;32(2):270–278. [PubMed] [Google Scholar]
  18. BRADLEY E. C. ACUTE BENIGN PERICARDITIS. Am Heart J. 1964 Jan;67:121–132. doi: 10.1016/0002-8703(64)90407-7. [DOI] [PubMed] [Google Scholar]
  19. Baker D. A., Phillips C. A. Fatal hand-foot-and-mouth disease in an adult caused by Coxsackievirus 47. JAMA. 1979 Sep 7;242(10):1065–1065. [PubMed] [Google Scholar]
  20. Balanian R. Structural and functional alterations in cultured cells infected with cytocidal viruses. Prog Med Virol. 1975;19:40–83. [PubMed] [Google Scholar]
  21. Balow J. E., Rosenthal A. S. Glucocorticoid suppression of macrophage migration inhibitory factor. J Exp Med. 1973 Apr 1;137(4):1031–1041. doi: 10.1084/jem.137.4.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Bandt C. M., Staley N. A., Noren G. R. Acute viral myocarditis. Clinical and histologic changes. Minn Med. 1979 Apr;62(4):234–237. [PubMed] [Google Scholar]
  23. Baxter J. D., Forsham P. H. Tissue effects of glucocorticoids. Am J Med. 1972 Nov;53(5):573–589. doi: 10.1016/0002-9343(72)90154-4. [DOI] [PubMed] [Google Scholar]
  24. Bayer M. E., Blumberg B. S., Werner B. Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature. 1968 Jun 15;218(5146):1057–1059. doi: 10.1038/2181057a0. [DOI] [PubMed] [Google Scholar]
  25. Bell E. J., Grist N. R. Coxsackie virus infections in patients with acute cardiac disease and chest pain. Scott Med J. 1968 Feb;13(2):47–51. doi: 10.1177/003693306801300204. [DOI] [PubMed] [Google Scholar]
  26. Bell E. J., Grist N. R. ECHO viruses, carditis, and acute pleurodynia. Am Heart J. 1971 Jul;82(1):133–135. doi: 10.1016/0002-8703(71)90173-6. [DOI] [PubMed] [Google Scholar]
  27. Bendinelli M., Ruschi A., Campa M., Toniolo A. Depression of humoral and cell-mediated immune responses by coxsackieviruses in mice. Experientia. 1975 Oct 15;31(10):1227–1229. doi: 10.1007/BF02326807. [DOI] [PubMed] [Google Scholar]
  28. Bengtsson E., Lamberger B. Five-year follow-up study of cases suggestive of acute myocarditis. Am Heart J. 1966 Dec;72(6):751–763. doi: 10.1016/0002-8703(66)90158-x. [DOI] [PubMed] [Google Scholar]
  29. Bennett N. M. Coxsackie B pericarditis. Med J Aust. 1966 Jul 23;2(4):178–179. doi: 10.5694/j.1326-5377.1966.tb73494.x. [DOI] [PubMed] [Google Scholar]
  30. Bergström K., Erikson U., Nordbring F., Nordgren B., Parrow A. Acute non-rheumatic myopericarditis: a follow-up study. Scand J Infect Dis. 1970;2(1):7–16. doi: 10.3109/inf.1970.2.issue-1.02. [DOI] [PubMed] [Google Scholar]
  31. Berjivich S., Ressel M. Effect of sex on susceptibility of adult mice to coxsackie B1 virus infection. Arch Gesamte Virusforsch. 1967;22(1):246–251. doi: 10.1007/BF01240519. [DOI] [PubMed] [Google Scholar]
  32. Berkovich S., Rodriguez-Torres R., Lin J. S. Virologic studies in children with acute myocarditis. Am J Dis Child. 1968 Feb;115(2):207–212. doi: 10.1001/archpedi.1968.02100010209009. [DOI] [PubMed] [Google Scholar]
  33. Burch G. E., Colcolough H. L. Progressive Coxsackie viral pancarditis and nephritis. Ann Intern Med. 1969 Nov;71(5):963–970. doi: 10.7326/0003-4819-71-5-963. [DOI] [PubMed] [Google Scholar]
  34. Burch G. E., Sun S. C., Colcolough H. L., Sohal R. S., DePasquale N. P. Coxsackie B viral myocarditis and valvulitis identified in routine autopsy specimens by immunofluorescent techniques. Am Heart J. 1967 Jul;74(1):13–23. doi: 10.1016/0002-8703(67)90035-x. [DOI] [PubMed] [Google Scholar]
  35. Burns W., Billups L. C., Notkins A. L. Thymus dependence of viral antigens. Nature. 1975 Aug 21;256(5519):654–656. doi: 10.1038/256654a0. [DOI] [PubMed] [Google Scholar]
  36. Buschard K., Rygaard J., Lung E. The inability of a diabetogenic virus to induce diabetes mellitus in athymic (nude) mice. Acta Pathol Microbiol Scand C. 1976 Aug;84(4):299–303. doi: 10.1111/j.1699-0463.1976.tb00033.x. [DOI] [PubMed] [Google Scholar]
  37. CHEEVER F. S. Multiplication of Coxsackie virus in adult mice exposed to roentgen radiation. J Immunol. 1953 Dec;71(6):431–435. [PubMed] [Google Scholar]
  38. CHRISTIAN H. A. Nearly ten decades of interest in idiopathic pericarditis. Am Heart J. 1951 Nov;42(5):645–651. doi: 10.1016/0002-8703(51)90169-x. [DOI] [PubMed] [Google Scholar]
  39. COLTMAN C. A., Jr Influenza myocarditis. Report of a case with observations on serum glutamic oxaloacetic transaminase. JAMA. 1962 Apr 21;180:204–208. doi: 10.1001/jama.1962.03050160020005. [DOI] [PubMed] [Google Scholar]
  40. COSSART Y. E., BURGES J. A. FATAL COXSACKIE B MYOCARDITIS IN AN ADULT. Med J Aust. 1965 Mar 6;1(10):337–338. doi: 10.5694/j.1326-5377.1965.tb71698.x. [DOI] [PubMed] [Google Scholar]
  41. Cambridge G., MacArthur C. G., Waterson A. P., Goodwin J. F., Oakley C. M. Antibodies to Coxsackie B viruses in congestive cardiomyopathy. Br Heart J. 1979 Jun;41(6):692–696. doi: 10.1136/hrt.41.6.692. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Cannell D. E. Myocardial Degenerations in Yellow Fever. Am J Pathol. 1928 Sep;4(5):431–443. [PMC free article] [PubMed] [Google Scholar]
  43. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  44. Cheetham H. D., Hart J., Coghill N. F., Fox B. Rabies with myocarditis. Two cases in England. Lancet. 1970 May 2;1(7653):921–922. doi: 10.1016/s0140-6736(70)91048-2. [DOI] [PubMed] [Google Scholar]
  45. Claman H. N., Moorhead J. W., Benner W. H. Corticosteroids and lymphoid cells in vitro. I. Hydrocortisone lysis of human, guinea pig, and mouse thymus cells. J Lab Clin Med. 1971 Oct;78(4):499–507. [PubMed] [Google Scholar]
  46. Craddock C. G., Winkelstein A., Matsuyuki Y., Lawrence J. S. The immune response to foreign red blood cells and the participation of short-lived lymphocytes. J Exp Med. 1967 Jun 1;125(6):1149–1172. doi: 10.1084/jem.125.6.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. DALGAARD J. B. Fatal myocarditis following smallpox vaccination. Am Heart J. 1957 Jul;54(1):156–157. doi: 10.1016/0002-8703(57)90090-x. [DOI] [PubMed] [Google Scholar]
  48. DALLDORF G., GIFFORD R. Susceptibility of gravid mice to Coxsackie virus infection. J Exp Med. 1954 Jan 1;99(1):21–27. doi: 10.1084/jem.99.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. DE JAGER H., VAN CREVELD S. Myocarditis in newborns, caused by coxsackie virus; clinical and pathological data. Ann Paediatr. 1956 Jul-Aug;187(1-2):100–118. [PubMed] [Google Scholar]
  50. DESANCTISMONALDI T., BENEDETTO A., TENTORIMONTALTO T. PERICARDITIS INFECTION DUE TO COXSACKIE VIRUS GROUP B, TYPE 2. Br Med J. 1963 Dec 7;2(5370):1451–1452. doi: 10.1136/bmj.2.5370.1451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. DIAS E., LARANJA F. S., MIRANDA A., NOBREGA G. Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation. 1956 Dec;14(6):1035–1060. doi: 10.1161/01.cir.14.6.1035. [DOI] [PubMed] [Google Scholar]
  52. DOLGOPOL V. B., GREENBERG M., ARONOFF R. Encephalitis following smallpox vaccination. AMA Arch Neurol Psychiatry. 1955 Feb;73(2):216–223. doi: 10.1001/archneurpsyc.1955.02330080094018. [DOI] [PubMed] [Google Scholar]
  53. Dalldorf G., Sickles G. M. An Unidentified, Filtrable Agent Isolated From the Feces of Children With Paralysis. Science. 1948 Jul 16;108(2794):61–62. doi: 10.1126/science.108.2794.61. [DOI] [PubMed] [Google Scholar]
  54. Doherty P. C., Blanden R. V., Zinkernagel R. M. Specificity of virus-immune effector T cells for H-2K or H-2D compatible interactions: implications for H-antigen diversity. Transplant Rev. 1976;29:89–124. doi: 10.1111/j.1600-065x.1976.tb00198.x. [DOI] [PubMed] [Google Scholar]
  55. Doherty P. C., Dunlop M. B., Parish C. R., Zinkernagel R. M. Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. J Immunol. 1976 Jul;117(1):187–190. [PubMed] [Google Scholar]
  56. Doherty P. C., Zinkernagel R. M., Ramshaw I. A. Specificity and development of cytotoxic thymus-derived lymphocytes in lymphocytic choriomeningitis. J Immunol. 1974 Apr;112(4):1548–1552. [PubMed] [Google Scholar]
  57. Droller M. J., Borg H., Perlmann P. In vitro enhancement of natural and antibody-dependent lymphocyte-mediated cytotoxicity against tumor target cells by interferon. Cell Immunol. 1979 Oct;47(2):248–260. doi: 10.1016/0008-8749(79)90335-6. [DOI] [PubMed] [Google Scholar]
  58. Effros R. B., Doherty P. C., Gerhard W., Bennink J. Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses. J Exp Med. 1977 Mar 1;145(3):557–568. doi: 10.1084/jem.145.3.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Ennis F. A., Martin W. J., Verbonitz M. W. Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med. 1977 Sep 1;146(3):893–898. doi: 10.1084/jem.146.3.893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  61. FISH M., BARTON H. R. Heart involvement in infections mononucleosis. AMA Arch Intern Med. 1958 Mar;101(3):636–644. doi: 10.1001/archinte.1958.00260150124016. [DOI] [PubMed] [Google Scholar]
  62. FLETCHER E., BRENNAN C. F. Cardiac complications of Coxsackie-virus infection. Lancet. 1957 May 4;272(6975):913–915. doi: 10.1016/s0140-6736(57)91229-1. [DOI] [PubMed] [Google Scholar]
  63. FRUHLING L., KORN R., LAVILLAUREIX J., SURJUS A., FOUSSEREAU S. [Chronic fibroelastic myoendocarditis of the newborn and the infant (fibroelastosis). New morphological, etiological and pathogenic data. Relation to certain cardiac abnormalities]. Ann Anat Pathol (Paris) 1962 Apr-Jun;7:227–303. [PubMed] [Google Scholar]
  64. Farber P. A., Glasgow L. A. Viral myocarditis during pregnancy: encephalomyocarditis virus infection in mice. Am Heart J. 1970 Jul;80(1):96–102. doi: 10.1016/0002-8703(70)90042-6. [DOI] [PubMed] [Google Scholar]
  65. Feinstone S. M., Hensley G. T., Rytel M. W. Post-coxsackie virus B3 myocardiopathy in mice. Proc Soc Exp Biol Med. 1973 Oct 1;144(1):345–350. [PubMed] [Google Scholar]
  66. Finberg R., Weiner H. L., Fields B. N., Benacerraf B., Burakoff S. J. Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A. 1979 Jan;76(1):442–446. doi: 10.1073/pnas.76.1.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Freij L., Norrby R., Olsson B. A small outbreak of Coxsackie B5 infection with two cases of cardiac involvement and orchitis followed by testicular atrophy. Acta Med Scand. 1970 Mar 3;187(3):177–181. doi: 10.1111/j.0954-6820.1970.tb02928.x. [DOI] [PubMed] [Google Scholar]
  68. French M. L., Schmidt N. J., Emmons R. W., Lennette E. H. Immunofluorescence staining of group B coxsackieviruses. Appl Microbiol. 1972 Jan;23(1):54–61. doi: 10.1128/am.23.1.54-61.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Frishman W., Kraus M. E., Zabkar J., Brooks V., Alonso D., Dixon L. M. Infectious mononucleosis and fatal myocarditis. Chest. 1977 Oct;72(4):535–538. doi: 10.1378/chest.72.4.535. [DOI] [PubMed] [Google Scholar]
  70. GALPINE J. F., WILSON W. C. Occurrence of myocarditis in paralytic poliomyelitis. Br Med J. 1959 Dec 19;2(5163):1379–1381. doi: 10.1136/bmj.2.5163.1379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. GEAR J., MEASROCH V., PRINSLOO F. R. The medical and public health importance of the Coxsackie viruses. S Afr Med J. 1956 Aug 25;30(34):806–810. [PubMed] [Google Scholar]
  72. GELFAND H. M., POTASH L., LEBLANC D. R., FOX J. P. Intrafamilial and interfamilial spread of living vaccine strains of polioviruses. J Am Med Assoc. 1959 Aug 22;170(17):2039–2048. doi: 10.1001/jama.1959.03010170001001. [DOI] [PubMed] [Google Scholar]
  73. GIFFORD R., DALLDORF G. The morbid anatomy of experimental Coxsackie virus infection. Am J Pathol. 1951 Nov-Dec;27(6):1047–1063. [PMC free article] [PubMed] [Google Scholar]
  74. GILES C., SHUTTLEWORTH E. M. Postmortem findings in 46 influenza deaths. Lancet. 1957 Dec 14;273(7007):1224–1225. doi: 10.1016/s0140-6736(57)90180-0. [DOI] [PubMed] [Google Scholar]
  75. GLAJCHEN D. Myocarditis due to Coxsackie virus infection in an adult. Br Med J. 1961 Sep 30;2(5256):870–871. doi: 10.1136/bmj.2.5256.870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. GODMAN G. C., BUNTING H., MELNICK J. L. The histopathology of Coxsackie virus infection in mice. I. Morphologic observations with four different viral types. Am J Pathol. 1952 Mar-Apr;28(2):223–257. [PMC free article] [PubMed] [Google Scholar]
  77. GOLDFIELD M., BOYER N. H., WEINSTEIN L. Electrocardiographic changes during the course of measles. J Pediatr. 1955 Jan;46(1):30–35. doi: 10.1016/s0022-3476(55)80235-1. [DOI] [PubMed] [Google Scholar]
  78. GRODUMS E. I., DEMPSTER G. Myocarditis in experimental Coxsackie B-3 infection. Can J Microbiol. 1959 Dec;5:605–615. doi: 10.1139/m59-074. [DOI] [PubMed] [Google Scholar]
  79. GRODUMS E. I., DEMPSTER G. The age factor in experimental Coxsackie B-3 infection. Can J Microbiol. 1959 Dec;5:595–604. doi: 10.1139/m59-073. [DOI] [PubMed] [Google Scholar]
  80. GRODUMS E. I., DEMPSTER G. The pathogenesis of Coxsackie group B viruses in experimental infection. Can J Microbiol. 1962 Feb;8:105–113. doi: 10.1139/m62-014. [DOI] [PubMed] [Google Scholar]
  81. Gardiner A. J., Short D. Four faces of acute myopericarditis. Br Heart J. 1973 Apr;35(4):433–442. doi: 10.1136/hrt.35.4.433. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Gardner I., Bowern N. A., Blanden R. V. Cell-mediated cytotoxicity against ectromelia virus-infected target cells. II. Identification of effector cells and analysis of mechanisms. Eur J Immunol. 1974 Feb;4(2):68–72. doi: 10.1002/eji.1830040203. [DOI] [PubMed] [Google Scholar]
  83. Gatmaitan B. G., Chason J. L., Lerner A. M. Augmentation of the virulence of murine coxsackie-virus B-3 myocardiopathy by exercise. J Exp Med. 1970 Jun 1;131(6):1121–1136. doi: 10.1084/jem.131.6.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. Gear J. H., Measroch V. Coxsackievirus infections of the newborn. Prog Med Virol. 1973;15:42–62. [PubMed] [Google Scholar]
  85. Godman G. C. The cytopathology of enteroviral infection. Int Rev Exp Pathol. 1966;5:67–110. [PubMed] [Google Scholar]
  86. Gorczynski R. M. Autoreactivity developing spontaneously in cultured mouse spleen cells. I. Evidence that cytotoxicity is directed against embryo-associated antigen. Immunology. 1976 Oct;31(4):607–614. [PMC free article] [PubMed] [Google Scholar]
  87. Gotsman M. S., Van der Horst R. L. Left ventricular aneurysm in rubella heart disease. Am J Dis Child. 1970 Sep;120(3):248–251. doi: 10.1001/archpedi.1970.02100080132015. [DOI] [PubMed] [Google Scholar]
  88. Grist N. R., Bell E. J. A six-year study of coxsackievirus B infections in heart disease. J Hyg (Lond) 1974 Oct;73(2):165–172. doi: 10.1017/s0022172400023998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Grist N. R., Bell E. J., Assaad F. Enteroviruses in human disease. Prog Med Virol. 1978;24:114–157. [PubMed] [Google Scholar]
  90. Grist N. R., Bell E. J. Coxsackie viruses and the heart. Am Heart J. 1969 Mar;77(3):295–300. doi: 10.1016/0002-8703(69)90184-7. [DOI] [PubMed] [Google Scholar]
  91. HACKEL D. B. Myocarditis in association with varicella. Am J Pathol. 1953 May-Jun;29(3):369–379. [PMC free article] [PubMed] [Google Scholar]
  92. HALONEN P., ROSEN L., HUEBNER R. J. Homologous and heterologous complement fixing antibody in persons infected with ECHO; Coxsackie and poliomyelitis viruses. Proc Soc Exp Biol Med. 1959 Jun;101(2):236–241. doi: 10.3181/00379727-101-24896. [DOI] [PubMed] [Google Scholar]
  93. HILDES J. A., SCHABERG A., ALCOCK A. J. Cardiovascular collapse in acute poliomyelitis. Circulation. 1955 Dec;12(6):986–993. doi: 10.1161/01.cir.12.6.986. [DOI] [PubMed] [Google Scholar]
  94. HOAGLAND R. J. Cardiac involvement in infectious mononucleosis. Am J Med Sci. 1956 Sep;232(3):252–257. [PubMed] [Google Scholar]
  95. HORSTMANN D. M. Acute poliomyelitis relation of physical activity at the time of onset to the course of the disease. J Am Med Assoc. 1950 Jan 28;142(4):236–241. doi: 10.1001/jama.1950.02910220016004. [DOI] [PubMed] [Google Scholar]
  96. HOUCK G. H. Involvement of the heart in infectious mononucleosis. Am J Med. 1953 Mar;14(3):261–264. doi: 10.1016/0002-9343(53)90037-0. [DOI] [PubMed] [Google Scholar]
  97. Hale A. H., Lyles D. S., Fan D. P. Elicitation of anti-Sendai virus cytotoxic T lymphocytes by viral and H-2 antigens incorporated into the same lipid bilayer by membrane fusion and by reconstitution into liposomes. J Immunol. 1980 Feb;124(2):724–731. [PubMed] [Google Scholar]
  98. Hashimoto I., Komatsu T. Myocardial changes after infection with Coxsackie virus B3 in nude mice. Br J Exp Pathol. 1978 Feb;59(1):13–20. [PMC free article] [PubMed] [Google Scholar]
  99. Helin M., Savola J., Lapinleimu K. Cardiac manifestations during a Coxsackie B5 epidemic. Br Med J. 1968 Jul 13;3(5610):97–99. doi: 10.1136/bmj.3.5610.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Helwig F. C., Schmidt C. H. A FILTER-PASSING AGENT PRODUCING INTERSTITIAL MYOCARDITIS IN ANTHROPOID APES AND SMALL ANIMALS. Science. 1945 Jul 13;102(2637):31–33. doi: 10.1126/science.102.2637.31. [DOI] [PubMed] [Google Scholar]
  101. Henson D., Mufson M. A. Myocarditis and pneumonitis with type 21 adenovirus infection. Association with fatal myocarditis and pneumonitis. Am J Dis Child. 1971 Apr;121(4):334–336. doi: 10.1001/archpedi.1971.02100150108015. [DOI] [PubMed] [Google Scholar]
  102. Hirschman S. Z., Hammer G. S. Coxsackie virus myopericarditis. A microbiological and clinical review. Am J Cardiol. 1974 Aug;34(2):224–232. doi: 10.1016/0002-9149(74)90201-x. [DOI] [PubMed] [Google Scholar]
  103. Hochman P. S., Cudkowicz G. Suppression of natural cytotoxicity by spleen cells of hydrocortisone-treated mice. J Immunol. 1979 Sep;123(3):968–976. [PubMed] [Google Scholar]
  104. Howard E. J., Maier H. C. Constrictive pericarditis following acute Coxsackie viral pericarditis. Am Heart J. 1968 Feb;75(2):247–250. doi: 10.1016/s0002-8703(68)90070-7. [DOI] [PubMed] [Google Scholar]
  105. Huber S. A., Job L. P., Woodruff J. F. Lysis of infected myofibers by coxsackievirus B-3-immune T lymphocytes. Am J Pathol. 1980 Mar;98(3):681–694. [PMC free article] [PubMed] [Google Scholar]
  106. Ito T., Su K. M., Murata M., Koizumi T., Matsumoto S., Ito Y., Kamiyama A. Experimental studies on the effect of glucocorticoids on cardiac muscle. Recent Adv Stud Cardiac Struct Metab. 1976 May 26;12:203–210. [PubMed] [Google Scholar]
  107. JAVETT S. N., HEYMANN S., MUNDEL B., PEPLER W. J., LURIE H. I., GEAR J., MEASROCH V., KIRSCH Z. Myocarditis in the new newborn infant; a study of an outbreak associated with Coxsackie group B virus infection in a maternity home in Johannesburg. J Pediatr. 1956 Jan;48(1):1–22. doi: 10.1016/s0022-3476(56)80111-x. [DOI] [PubMed] [Google Scholar]
  108. JUNGEBLUT C. W., EDWARDS J. E. Isolation of poliomyelitis virus from the heart in fatal cases. Am J Clin Pathol. 1951 Jul;21(7):601–623. doi: 10.1093/ajcp/21.7.601. [DOI] [PubMed] [Google Scholar]
  109. Jaśkiewicz K. Pathogenesis of chronic myocarditis in mice infected with coxsackie B3 viruses. Arch Immunol Ther Exp (Warsz) 1979;27(1-2):89–97. [PubMed] [Google Scholar]
  110. Jaśkiewicz K. Trials of treating myocarditis in mice infected with coxsackie B3 viruses. Arch Immunol Ther Exp (Warsz) 1979;27(1-2):99–103. [PubMed] [Google Scholar]
  111. Jennings R. C. Coxsackie group B fatal neonatal myocarditis associated with cardiomegaly. J Clin Pathol. 1966 Jul;19(4):325–327. doi: 10.1136/jcp.19.4.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. KIBRICK S., BENIRSCHKE K. Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent. Pediatrics. 1958 Nov;22(5):857–875. [PubMed] [Google Scholar]
  113. KIBRICK S. CURRENT STATUS OF COXSACKIE AND ECHO VIRUSES IN HUMAN DISEASE. Prog Med Virol. 1964;6:27–70. [PubMed] [Google Scholar]
  114. KILBOURNE E. D., HORSFALL F. L., Jr Lethal infection with coxsackie virus of adult mice given cortisone. Proc Soc Exp Biol Med. 1951 May;77(1):135–138. doi: 10.3181/00379727-77-18702. [DOI] [PubMed] [Google Scholar]
  115. KILBOURNE E. D., WILSON C. B., PERRIER D. The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone. J Clin Invest. 1956 Apr;35(4):362–370. doi: 10.1172/JCI103286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  116. KIPKIE G. F., McAULEY J. S. Acute myocarditis occurring in bulbar poliomyelitis. Can Med Assoc J. 1954 Mar;70(3):315–317. [PMC free article] [PubMed] [Google Scholar]
  117. KLINE I. K., SAPHIR O. Chronic pernicious myocarditis. Am Heart J. 1960 May;59:681–697. doi: 10.1016/0002-8703(60)90510-x. [DOI] [PubMed] [Google Scholar]
  118. Kapikian A. Z., Wyatt R. G., Dolin R., Thornhill T. S., Kalica A. R., Chanock R. M. Visualization by immune electron microscopy of a 27-nm particle associated with acute infectious nonbacterial gastroenteritis. J Virol. 1972 Nov;10(5):1075–1081. doi: 10.1128/jvi.10.5.1075-1081.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Kawai C. Idiopathic cardiomyopathy. A study on the infectious-immune theory as a cause of the disease. Jpn Circ J. 1971 Jul;35(7):765–770. doi: 10.1253/jcj.35.765. [DOI] [PubMed] [Google Scholar]
  120. Kiessling R., Klein E., Pross H., Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol. 1975 Feb;5(2):117–121. doi: 10.1002/eji.1830050209. [DOI] [PubMed] [Google Scholar]
  121. Koontz C. H., Ray C. G. The role of Coxsackie group B virus infections in sporadic myopericarditis. Am Heart J. 1971 Dec;82(6):750–758. doi: 10.1016/0002-8703(71)90195-5. [DOI] [PubMed] [Google Scholar]
  122. Koszinowski U., Ertl H. Lysis mediated by T cells and restricted by H-2 antigen of target cells infected with vaccinia virus. Nature. 1975 Jun 12;255(5509):552–554. doi: 10.1038/255552a0. [DOI] [PubMed] [Google Scholar]
  123. LAAKE H. Myocarditis in poliomyelitis. Acta Med Scand. 1951 Jul 23;140(3):159–169. doi: 10.1111/j.0954-6820.1951.tb10168.x. [DOI] [PubMed] [Google Scholar]
  124. LENNETTE E. H., SHINOMOTO T. T., SCHMIDT N. J., MAGOFFIN R. L. Observations on the neutralizing antibody response to group B Coxsackie viruses in patients with central nervous system disease. J Immunol. 1961 Mar;86:257–266. [PubMed] [Google Scholar]
  125. LOU T. Y., WENNER H. A., KAMITSUKA P. S. Experimental infections with Coxackie viruses. II. Myocarditis in Cynomolgus monkeys infected with B 4 virus. Arch Gesamte Virusforsch. 1961;10:451–464. [PubMed] [Google Scholar]
  126. LUDDEN T. E., EDWARDS J. E. Carditis in poliomyelitis; an anatomic study of 35 cases and review of the literature. Am J Pathol. 1949 May;25(3):357–381. [PMC free article] [PubMed] [Google Scholar]
  127. Lee F. K., Nahmias A. J., Stagno S. Rapid diagnosis of cytomegalovirus infection in infants by electron microscopy. N Engl J Med. 1978 Dec 7;299(23):1266–1270. doi: 10.1056/NEJM197812072992302. [DOI] [PubMed] [Google Scholar]
  128. Lerner A. M. Coxsackievirus myocardiopathy. J Infect Dis. 1969 Oct;120(4):496–499. doi: 10.1093/infdis/120.4.496. [DOI] [PubMed] [Google Scholar]
  129. Lerner A. M., Wilson F. M. Virus myocardiopathy. Prog Med Virol. 1973;15:63–91. [PubMed] [Google Scholar]
  130. Lewes D., Rainford D. J., Lane W. F. Symptomless myocarditis and myalgia in viral and Mycoplasma pneumoniae infections. Br Heart J. 1974 Sep;36(9):924–932. doi: 10.1136/hrt.36.9.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  131. Liao S. Cellular receptors and mechanisms of action of steroid hormones. Int Rev Cytol. 1975;41:87–172. doi: 10.1016/s0074-7696(08)60967-5. [DOI] [PubMed] [Google Scholar]
  132. Longson M., Cole F. M., Davies D. Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult. J Clin Pathol. 1969 Nov;22(6):654–658. doi: 10.1136/jcp.22.6.654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Loria R. M., Kibrick S., Madge G. E. Infection of hypercholesterolemic mice with Coxsackievirus B. J Infect Dis. 1976 Jun;133(6):655–662. doi: 10.1093/infdis/133.6.655. [DOI] [PubMed] [Google Scholar]
  134. MADDOCK R. K., Jr INCIDENCE OF SYSTEMIC LUPUS ERYTHEMATOSUS BY AGE AND SEX. JAMA. 1965 Jan 11;191:137–138. doi: 10.1001/jama.1965.03080020065026. [DOI] [PubMed] [Google Scholar]
  135. MEDEARIS D. N., Jr Cytomegalic inclusion disease; an analysis of the clinical features based on the literature and six additional cases. Pediatrics. 1957 Mar;19(3):467–480. [PubMed] [Google Scholar]
  136. MELLORS R. C., ORTEGA L. G., HOLMAN H. R. Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction. J Exp Med. 1957 Aug 1;106(2):191–202. doi: 10.1084/jem.106.2.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. MELNICK J. L., GODMAN G. C. Pathogenesis of coxsackie virus infection; multiplication of virus and evolution of the muscle lesion in mice. J Exp Med. 1951 Mar;93(3):247–266. doi: 10.1084/jem.93.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. MELNICK J. L., KAPLAN A. S. Quantitative studies of the virus-host relationship in chimpanzees after inapparent infection with Coxsackie viruses. I. The virus carrier state and the development of neutralizing antibodies. J Exp Med. 1953 Mar;97(3):367–400. doi: 10.1084/jem.97.3.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. MONTGOMERY J., GEAR J., PRINSLOO F. R., KAHN M., KIRSCH Z. G. Myocarditis of the newborn; an outbreak in a maternity home in Southern Rhodesia associated with Coxsackie group-B virus infection. S Afr Med J. 1955 Jun 25;29(26):608–612. [PubMed] [Google Scholar]
  140. Masi A. T., Kaslow R. A. Sex effects in systemic lupus erythematosus: a clue to pathogenesis. Arthritis Rheum. 1978 May;21(4):480–484. doi: 10.1002/art.1780210413. [DOI] [PubMed] [Google Scholar]
  141. McFarland H. F. In vitro studies of cell-mediated immunity in an acute viral infection. J Immunol. 1974 Jul;113(1):173–180. [PubMed] [Google Scholar]
  142. Minkowitz S., Berkovich S. Hepatitis produced by coxsackievirus B1 in adult mice. Arch Pathol. 1970 May;89(5):427–433. [PubMed] [Google Scholar]
  143. Monif G. R., Lee C. W., Hsiung G. D. Isolated myocarditis with recovery of ECHO type 9 virus from the myocardium. N Engl J Med. 1967 Dec 21;277(25):1353–1355. doi: 10.1056/NEJM196712212772506. [DOI] [PubMed] [Google Scholar]
  144. Moore C. M., Henry J., Benzing G., 3rd, Kaplan S. Varicella myocarditis. Am J Dis Child. 1969 Dec;118(6):899–902. doi: 10.1001/archpedi.1969.02100040901016. [DOI] [PubMed] [Google Scholar]
  145. Morales A. R., Adelman S., Fine G. Varicella myocarditis. A case of sudden death. Arch Pathol. 1971 Jan;91(1):29–31. [PubMed] [Google Scholar]
  146. Morgante O., Ambrosie E. P., Haraphongse M., Lam R. P., Fraser R. S. Conjugation of coxsackievirus type B1-B6 immunoglobulins with fluorescein isothiocyanate by a "reversed" dialysis method. J Infect Dis. 1978 Jun;137(6):802–809. doi: 10.1093/infdis/137.6.802. [DOI] [PubMed] [Google Scholar]
  147. Norris D., Loh P. C. Coxsackievirus myocarditis: prophylaxis and therapy with an interferon stimulator. Proc Soc Exp Biol Med. 1973 Jan;142(1):133–136. doi: 10.3181/00379727-142-36975. [DOI] [PubMed] [Google Scholar]
  148. OSEASOHN R., ADELSON L., KAJI M. Clinicopathologic study of thirty-three fatal cases of Asian influenza. N Engl J Med. 1959 Mar 12;260(11):509–518. doi: 10.1056/NEJM195903122601101. [DOI] [PubMed] [Google Scholar]
  149. Obeyesekere I., Hermon Y. Myocarditis and cardiomyopathy after arbovirus infections (dengue and chikungunya fever). Br Heart J. 1972 Aug;34(8):821–827. doi: 10.1136/hrt.34.8.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Okuni M., Yamada T., Mochizuki S., Sakurai I. Studies on myocarditis in childhood, with special reference to the possible role of immunological process and the thymus in the chronicity of the disease. Jpn Circ J. 1975 Apr;39(4):463–470. doi: 10.1253/jcj.39.463. [DOI] [PubMed] [Google Scholar]
  151. Oldstone M. B. Virus neutralization and virus-induced immune complex disease. Virus-antibody union resulting in immunoprotection or immunologic injury--two sides of the same coin. Prog Med Virol. 1975;19:84–119. [PubMed] [Google Scholar]
  152. PAPPENHEIMER A. M., DANIELS J. B., CHEEVER F. S., WELLER T. H. Lesions caused in suckling mice by certain viruses isolated from cases of so called non-paralytic poliomyelitis and of pleurodynia. J Exp Med. 1950 Aug;92(2):169–190. doi: 10.1084/jem.92.2.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. PAPPENHEIMER A. M., KUNZ L. J., RICHARDSON S. Passage of Coxsackie virus (Connecticut-5 strain) in adult mice with production of pancreatic disease. J Exp Med. 1951 Jul 1;94(1):45–64. doi: 10.1084/jem.94.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  154. PEARCE J. M. Heart disease and filtrable viruses. Circulation. 1960 Mar;21:448–455. doi: 10.1161/01.cir.21.3.448. [DOI] [PubMed] [Google Scholar]
  155. PLAGER H., BEEBE R., MILLER J. K. Coxsackie B-5 pericarditis in pregnancy. Arch Intern Med. 1962 Nov;110:735–738. doi: 10.1001/archinte.1962.03620230181024. [DOI] [PubMed] [Google Scholar]
  156. Papoian R., Pillarisetty R., Talal N. Immunological regulation of spontaneous antibodies to DNA and RNA. II. Sequential switch from IgM to IgG in NZB/NZW F1 mice. Immunology. 1977 Jan;32(1):75–79. [PMC free article] [PubMed] [Google Scholar]
  157. Paque R. E., Gauntt C. J., Nealon T. J., Trousdale M. D. Assessment of cell-mediated hypersensitivity against coxsackievirus B3 viral-induced myocarditis utilizing hypertonic salt extracts of cardiac tissue. J Immunol. 1978 May;120(5):1672–1678. [PubMed] [Google Scholar]
  158. Paque R. E., Straus D. C., Nealon T. J., Gauntt C. J. Fractionation and immunologic assessment of KCl-extracted cardiac antigens in coxsackievirus B3 virus-induced myocarditis. J Immunol. 1979 Jul;123(1):358–364. [PubMed] [Google Scholar]
  159. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  160. Pfizenmaier K., Starzinski-Powitz A., Röllinghoff M., Falks D., Wagner H. T-cell-mediated cytotoxicity against herpes simplex virus-infected target cells. Nature. 1977 Feb 17;265(5595):630–632. doi: 10.1038/265630a0. [DOI] [PubMed] [Google Scholar]
  161. Price R. A., Garcia J. H., Rightsel W. A. Choriomeningitis and myocarditis in an adolescent with isolation of coxsackie B-5 virus. Am J Clin Pathol. 1970 Jun;53(6):825–831. doi: 10.1093/ajcp/53.6.825. [DOI] [PubMed] [Google Scholar]
  162. QUITTNER H., WALD N., SUSSMAN L. N., ANTOPOL W. The effect of massive doses of cortisone on the peripheral blood and bone marrow of the mouse. Blood. 1951 Jun;6(6):513–521. [PubMed] [Google Scholar]
  163. RABIN E. R., HASSAN S. A., JENSON A. B., MELNICK J. L. COXSACKIE VIRUS B3 MYOCARDITIS IN MICE. AN ELECTRON MICROSCOPIC, IMMUNOFLUORESCENT AND VIRUS-ASSAY STUDY. Am J Pathol. 1964 May;44:775–797. [PMC free article] [PubMed] [Google Scholar]
  164. ROBERTS G. B., BAIN A. D. The pathology of measles. J Pathol Bacteriol. 1958 Jul;76(1):111–118. doi: 10.1002/path.1700760112. [DOI] [PubMed] [Google Scholar]
  165. ROBERTS R., LYDON M., MACINTOSH M. Coxsackie pericarditis. Can Med Assoc J. 1959 May 1;80(9):722–725. [PMC free article] [PubMed] [Google Scholar]
  166. ROSENBAUM H. E., HARFORD C. G. Effect of fatigue on susceptibility of mice to poliomyelitis. Proc Soc Exp Biol Med. 1953 Aug-Sep;83(4):678–681. doi: 10.3181/00379727-83-20456. [DOI] [PubMed] [Google Scholar]
  167. ROSS E., ARMENTROUT S. A. Myocarditis associated with rabies. Report of a case. N Engl J Med. 1962 May 24;266:1087–1089. doi: 10.1056/NEJM196205242662105. [DOI] [PubMed] [Google Scholar]
  168. ROSS L. J. Electrocardiographic findings in measles. AMA Am J Dis Child. 1952 Mar;83(3):282–291. doi: 10.1001/archpedi.1952.02040070028002. [DOI] [PubMed] [Google Scholar]
  169. Rabin E. R., Melnick J. L. Viral myocarditis. Cardiovasc Res Cent Bull. 1965 Jul-Sep;4(1):2–4. [PubMed] [Google Scholar]
  170. Rabinovitch M., Manejias R. E., Russo M., Abbey E. E. Increased spreading of macrophages from mice treated with interferon inducers. Cell Immunol. 1977 Mar 1;29(1):86–95. doi: 10.1016/0008-8749(77)90277-5. [DOI] [PubMed] [Google Scholar]
  171. Rager-Zisman B., Allison A. C. Effects of immunosuppression on coxsackie B-3 virus infection in mice, and passive protection by circulating antibody. J Gen Virol. 1973 Jun;19(3):339–351. doi: 10.1099/0022-1317-19-3-339. [DOI] [PubMed] [Google Scholar]
  172. Rager-Zisman B., Allison A. C. The role of antibody and host cells in the resistance of mice against infection by coxsackie B-3 virus. J Gen Virol. 1973 Jun;19(3):329–338. doi: 10.1099/0022-1317-19-3-329. [DOI] [PubMed] [Google Scholar]
  173. Roberts W. C., Fox S. M., 3rd Mumps of the heart. Clinical and pathologic features. Circulation. 1965 Sep;32(3):342–345. doi: 10.1161/01.cir.32.3.342. [DOI] [PubMed] [Google Scholar]
  174. Robinson J. A., O'Connell J., Henkin R. E., Gunnar R. M. Gallium-67 imaging in cardiomyopathy. Ann Intern Med. 1979 Feb;90(2):198–199. doi: 10.7326/0003-4819-90-2-198. [DOI] [PubMed] [Google Scholar]
  175. Roesing T. G., Landau B. J., Crowell R. L. Limited persistence of viral antigen in coxsackievirus B3 induced heart disease in mice. Proc Soc Exp Biol Med. 1979 Mar;160(3):382–386. doi: 10.3181/00379727-160-40455. [DOI] [PubMed] [Google Scholar]
  176. Rose H. D. Recurrent illness following acute coxsackie B 4 myocarditis. Am J Med. 1973 Apr;54(4):544–548. doi: 10.1016/0002-9343(73)90052-1. [DOI] [PubMed] [Google Scholar]
  177. Roubinian J. R., Papoian R., Talal N. Androgenic hormones modulate autoantibody responses and improve survival in murine lupus. J Clin Invest. 1977 Jun;59(6):1066–1070. doi: 10.1172/JCI108729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Russell S. J., Bell E. J. Echoviruses and carditis. Lancet. 1970 Apr 11;1(7650):784–785. doi: 10.1016/s0140-6736(70)91021-4. [DOI] [PubMed] [Google Scholar]
  179. Rytel M. W. Interferon response during Coxsackie B-3 infection in mice. I. The effect of cortisone. J Infect Dis. 1969 Sep;120(3):379–382. doi: 10.1093/infdis/120.3.379. [DOI] [PubMed] [Google Scholar]
  180. Rytel M. W., Kilbourne E. D. The influence of cortisone on experimental viral infection. 8. Suppression by cortisone of interferon formation in mice injected with Newcastle disease virus. J Exp Med. 1966 May 1;123(5):767–775. doi: 10.1084/jem.123.5.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  181. Rühl H., Vogt W., Bochert G., Schmidt S., Moelle R., Schaoua H. Effect of L-asparaginase and hydrocortisone on human lymphocyte transformation and production of a mononuclear leucocyte chemotactic factor in vitro. Immunology. 1974 May;26(5):989–994. [PMC free article] [PubMed] [Google Scholar]
  182. SAMPSON C. C. Varicella myocarditis; report of a case. J Natl Med Assoc. 1959 Mar;51(2):138–139. [PMC free article] [PubMed] [Google Scholar]
  183. SANDERS V. VIRAL MYOCARDITIS. Am Heart J. 1963 Nov;66:707–713. doi: 10.1016/0002-8703(63)90328-4. [DOI] [PubMed] [Google Scholar]
  184. SANGHVI L. M., MISRA S. N. Electrocardiographic abnormalities in epidemic hepatitis. Circulation. 1957 Jul;16(1):88–94. doi: 10.1161/01.cir.16.1.88. [DOI] [PubMed] [Google Scholar]
  185. SANYAL S. K., MAHDAVY M., GABRIELSON M. O., VIDONE R. A., BROWNE M. J. FATAL MYOCARDITIS IN AN ADOLESCENT CAUSED BY COXSACKIE VIRUS, GROUP B, TYPE FOUR. Pediatrics. 1965 Jan;35:36–41. [PubMed] [Google Scholar]
  186. SAPHIR O., AMROMIN G. D., YOKOO H. Myocarditis in viral (epidemic) hepatitis. Am J Med Sci. 1956 Feb;231(2):168–176. [PubMed] [Google Scholar]
  187. SAPHIR O., COHEN N. A. Myocarditis in infancy. AMA Arch Pathol. 1957 Oct;64(4):446–456. [PubMed] [Google Scholar]
  188. SHWARTZMAN G. Enhancing effect of cortisone upon poliomyelitis infection (Strain MEF1) in hamsters and mice. Proc Soc Exp Biol Med. 1950 Dec;75(3):835–838. doi: 10.3181/00379727-75-18362. [DOI] [PubMed] [Google Scholar]
  189. SHWARTZMAN G., FISHER A. Alteration of experimental poliomyelitis infection in the Syrian hamster with the aid of cortisone. J Exp Med. 1952 Apr;95(4):347–362. doi: 10.1084/jem.95.4.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. SPAIN D. M., BRADESS V. A., PARSONNET V. Myocarditis in poliomyelitis. Am Heart J. 1950 Sep;40(3):336–344. doi: 10.1016/0002-8703(50)90315-2. [DOI] [PubMed] [Google Scholar]
  191. STRACHAN R. W. RELAPSING COXSACKIE PERICARDITIS SIMULATING MYOCARDIAL INFARCTION AND DA COSTA'S SYNDROME. Scott Med J. 1963 Oct;8:402–408. doi: 10.1177/003693306300801004. [DOI] [PubMed] [Google Scholar]
  192. SYMMERS W. S. Generalized cytomegalic inclusion-body disease associated with pneumocystis pneumonia in adults. A report of three cases. with Wegener's granulomatosis. thrombotic purpura, and Hodgkin's disease as predisposing conditions. J Clin Pathol. 1960 Jan;13:1–21. doi: 10.1136/jcp.13.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Sainani G. S., Krompotic E., Slodki S. J. Adult heart disease due to the Coxsackie virus B infection. Medicine (Baltimore) 1968 Mar;47(2):133–147. doi: 10.1097/00005792-196803000-00003. [DOI] [PubMed] [Google Scholar]
  194. Schmidt N. J., Lennette E. H., Dennis J. Characterization of antibodies produced in natural and experimental coxsackievirus infections. J Immunol. 1968 Jan;100(1):99–106. [PubMed] [Google Scholar]
  195. Schmidt N. J., Lennette E. H., Dennis J. Hemagglutination-inhibiting antibody responses in human infections with group B coxsackieviruses. J Immunol. 1966 Feb;96(2):311–318. [PubMed] [Google Scholar]
  196. Smith W. G. Coxsackie B myopericarditis in adults. Am Heart J. 1970 Jul;80(1):34–46. doi: 10.1016/0002-8703(70)90035-9. [DOI] [PubMed] [Google Scholar]
  197. Stevens P. J., Ground K. E. Occurrence and significance of myocarditis in trauma. Aerosp Med. 1970 Jul;41(7):776–780. [PubMed] [Google Scholar]
  198. Sutinen S., Kalliomäki J. L., Pohjonen R., Vastamäki R. Fatal generalized coxsackie B3 virus infection in an adolescent with successful isolation of the virus from pericardial fluid. Ann Clin Res. 1971 Aug;3(4):241–246. [PubMed] [Google Scholar]
  199. Sutton G. C., Morrissey R. A., Tobin J. R., Jr, Anderson T. O. Pericardial and myocardial disease associated with serological evidence of infection by agents of the psittacosis-lymphogranuloma venereum group (Chamydiaceae). Circulation. 1967 Dec;36(6):830–838. doi: 10.1161/01.cir.36.6.830. [DOI] [PubMed] [Google Scholar]
  200. TATTER D., GERARD P. W., SILVERMAN A. H., WANG C. I., PEARSON H. E. FATAL VARICELLA PANCARDITIS IN A CHILD. Am J Dis Child. 1964 Jul;108:88–93. doi: 10.1001/archpedi.1964.02090010090012. [DOI] [PubMed] [Google Scholar]
  201. THIEDE W. H. Cardiac involvement in lymphocytic choriomeningitis. Arch Intern Med. 1962 Jan;109:50–54. doi: 10.1001/archinte.1962.03620130052008. [DOI] [PubMed] [Google Scholar]
  202. TILLES J. G., ELSON S. H., SHAKA J. A., ABELMANN W. H., LERNER A. M., FINLAND M. EFFECTS OF EXERCISE ON COXSACKIE A9 MYOCARDITIS IN ADULT MICE. Proc Soc Exp Biol Med. 1964 Dec;117:777–782. doi: 10.3181/00379727-117-29696. [DOI] [PubMed] [Google Scholar]
  203. Talal N. Disordered immunologic regulation and autoimmunity. Transplant Rev. 1976;31:240–263. doi: 10.1111/j.1600-065x.1976.tb01456.x. [DOI] [PubMed] [Google Scholar]
  204. Thompson J., van Furth R. The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J Exp Med. 1970 Mar 1;131(3):429–442. doi: 10.1084/jem.131.3.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  205. Thompson J., van Furth R. The effect of glucocorticosteroids on the proliferation and kinetics of promonocytes and monocytes of the bone marrow. J Exp Med. 1973 Jan 1;137(1):10–21. doi: 10.1084/jem.137.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Trinchieri G., Santoli D. Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis. J Exp Med. 1978 May 1;147(5):1314–1333. doi: 10.1084/jem.147.5.1314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Töndury G., Smith D. W. Fetal rubella pathology. J Pediatr. 1966 Jun;68(6):867–879. doi: 10.1016/s0022-3476(66)80204-4. [DOI] [PubMed] [Google Scholar]
  208. VOSTI G. J., ROFFWARG H. Myocarditis and encephalitis in a case of suspected psittacosis. Ann Intern Med. 1961 Apr;54:764–776. doi: 10.7326/0003-4819-54-4-764. [DOI] [PubMed] [Google Scholar]
  209. WEINSTEIN L., AYCOCK W. L., FEEMSTER R. F. The relation of sex, pregnancy and menstruation to susceptibility in poliomyelitis. N Engl J Med. 1951 Jul 12;245(2):54–58. doi: 10.1056/NEJM195107122450203. [DOI] [PubMed] [Google Scholar]
  210. WEINSTEIN L., SHELOKOV A. Cardiovascular manifestations in acute poliomyelitis. N Engl J Med. 1951 Feb 22;244(8):281–285. doi: 10.1056/NEJM195102222440802. [DOI] [PubMed] [Google Scholar]
  211. WENNER H. A., LOU T. Y., KAMITSUKA P. S. Experimental infections with Coxsackie viruses. I. Studies on virulence and pathogenesis in Cynomolgus monkeys. Arch Gesamte Virusforsch. 1961;10:426–450. [PubMed] [Google Scholar]
  212. WIGAND R., SABIN A. B. Properties of epidemic strains of ECHO type 9 virus and observations on the nature of human infection. Arch Gesamte Virusforsch. 1962;11:683–707. doi: 10.1007/BF01243308. [DOI] [PubMed] [Google Scholar]
  213. WILSON D. R., LENKEI S. C., PATERSON J. F. Acute constrictive epicarditis following infectious mononucleosis; case report. Circulation. 1961 Feb;23:257–260. doi: 10.1161/01.cir.23.2.257. [DOI] [PubMed] [Google Scholar]
  214. Webb S. R., Loria R. M., Madge G. E., Kibrick S. Susceptibility of mice to group B coxsackie virus is influenced by the diabetic gene. J Exp Med. 1976 May 1;143(5):1239–1248. doi: 10.1084/jem.143.5.1239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  215. Welsh R. M., Jr Mouse natural killer cells: induction specificity, and function. J Immunol. 1978 Nov;121(5):1631–1635. [PubMed] [Google Scholar]
  216. Werb Z., Foley R., Munck A. Glucocorticoid receptors and glucocorticoid-sensitive secretion of neutral proteinases in a macrophage line. J Immunol. 1978 Jul;121(1):115–121. [PubMed] [Google Scholar]
  217. Wiener E., Marmary Y., Curelaru Z. The in vitro effect of hydrocortisone on the uptake and intracellular digestion of particulate matter by macrophages in culture. Lab Invest. 1972 Feb;26(2):220–226. [PubMed] [Google Scholar]
  218. Wilfert C. M., Buckley R. H., Mohanakumar T., Griffith J. F., Katz S. L., Whisnant J. K., Eggleston P. A., Moore M., Treadwell E., Oxman M. N. Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia. N Engl J Med. 1977 Jun 30;296(26):1485–1489. doi: 10.1056/NEJM197706302962601. [DOI] [PubMed] [Google Scholar]
  219. Wilson F. M., Miranda Q. R., Chason J. L., Lerner A. M. Residual pathologic changes following murine coxsackie A and B myocarditis. Am J Pathol. 1969 May;55(2):253–265. [PMC free article] [PubMed] [Google Scholar]
  220. Wong C. Y., Woodruff J. J., Woodruff J. F. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. I. Model and viral specificity1. J Immunol. 1977 Apr;118(4):1159–1164. [PubMed] [Google Scholar]
  221. Wong C. Y., Woodruff J. J., Woodruff J. F. Generation of cytotoxic T lymphocytes during coxsackievirus B-3 infection. III. Role of sex. J Immunol. 1977 Aug;119(2):591–597. [PubMed] [Google Scholar]
  222. Wong C. Y., Woodruff J. J., Woodruff J. F. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1. J Immunol. 1977 Apr;118(4):1165–1169. [PubMed] [Google Scholar]
  223. Woodruff J. F., Kilbourne E. D. The influence of quantitated post-weaning undernutrition on coxsackievirus B3 infection of adult mice. I. Viral persistence and increased severity of lesions. J Infect Dis. 1970 Feb;121(2):137–163. doi: 10.1093/infdis/121.2.137. [DOI] [PubMed] [Google Scholar]
  224. Woodruff J. F. Lack of correlation between neutralizing antibody production and suppression of coxsackievirus B-3 replication in target organs: evidence for involvement of mononuclear inflammatory cells in host defense. J Immunol. 1979 Jul;123(1):31–36. [PubMed] [Google Scholar]
  225. Woodruff J. F. The influence of quantitated post-weaning undernutrition on coxsackievirus B3 infection of adult mice. II. Alteration of host defense mechanisms. J Infect Dis. 1970 Feb;121(2):164–181. doi: 10.1093/infdis/121.2.164. [DOI] [PubMed] [Google Scholar]
  226. Woodruff J. F., Woodruff J. J. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J Immunol. 1974 Dec;113(6):1726–1734. [PubMed] [Google Scholar]
  227. Woodward T. E., Togo Y., Lee Y. C., Hornick R. B. Specific microbial infections of the myocardium and pericardium. A study of 82 patients. Arch Intern Med. 1967 Sep;120(3):270–279. [PubMed] [Google Scholar]
  228. Yoon J. W., Austin M., Onodera T., Notkins A. L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med. 1979 May 24;300(21):1173–1179. doi: 10.1056/NEJM197905243002102. [DOI] [PubMed] [Google Scholar]
  229. Yoon J. W., Onodera T., Notkins A. L. Virus-induced diabetes mellitus. XV. Beta cell damage and insulin-dependent hyperglycemia in mice infected with coxsackie virus B4. J Exp Med. 1978 Oct 1;148(4):1068–1080. doi: 10.1084/jem.148.4.1068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  230. ZINSSER H. F., BLAKEMORE W. S., KIRBY C. K., JOHNSON J. Invalidism due to recurrent idiopathic pericarditis with recovery after pericardiectomy. J Am Med Assoc. 1959 Sep 19;171:274–277. doi: 10.1001/jama.1959.03010210026008. [DOI] [PubMed] [Google Scholar]
  231. Zinkernagel R. M., Callahan G. N., Althage A., Cooper S., Streilein J. W., Klein J. The lymphoreticular system in triggering virus plus self-specific cytotoxic T cells: evidence for T help. J Exp Med. 1978 Mar 1;147(3):897–911. doi: 10.1084/jem.147.3.897. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES